Distinct Immunophenotypic Profiles and Neutrophil Heterogeneity in Colorectal Cancer
Minghua Bai,
No information about this author
Yuzhao Jin,
No information about this author
Zihao Jin
No information about this author
et al.
Cancer Letters,
Journal Year:
2025,
Volume and Issue:
616, P. 217570 - 217570
Published: Feb. 22, 2025
Language: Английский
GNGT1 remodels the tumor microenvironment and promotes immune escape through enhancing tumor stemness and modulating the fibrinogen beta chain-neutrophil extracellular trap signaling axis in lung adenocarcinoma
Linlin Fan,
No information about this author
Xiaowei Wang,
No information about this author
Xiu‐Mei Zhang
No information about this author
et al.
Translational Lung Cancer Research,
Journal Year:
2025,
Volume and Issue:
14(1), P. 239 - 259
Published: Jan. 1, 2025
Despite
the
recent
advancements
in
treatment
of
cancer,
5-year
survival
patients
with
non-small
cell
lung
cancer
(NSCLC)
remains
unsatisfactory.
Lung
adenocarcinoma
(LUAD)
is
NSCLC's
most
common
subtype,
and
metastasis
major
cause
death
cancer.
Therefore,
identifying
novel
targets
associated
NSCLC
crucial
to
improving
treatment.
This
study
aimed
characterize
expression
GNGT1
LUAD
clarify
mechanism
underlying
association
between
higher
level
worse
prognosis
patients.
The
transcriptome
datasets
clinical
information
were
obtained
from
Cancer
Genome
Atlas
(TCGA)
Gene
Expression
Omnibus
(GEO)
database.
Bioinformatics
analyses
performed
515
who
stratified
into
two
groups
(high-
low-GNGT1
group)
according
level.
Overall
survival,
DNA
promotor
methylation,
immune
infiltration,
gene
set
enrichment
analysis
(GSEA),
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
elucidate
functions
identify
related
hub
genes
LUAD.
Their
verified
using
tissues
transgenic
mice
overexpressing
under
control
a
lung-specific
promoter
(Scgb1a1-Cre).
was
overexpressed
poor
prognosis.
significantly
correlated
alteration
hypomethylated
status.
High
advanced
lymph
node
degree
infiltration.
Functional
indicated
that
differentially
expressed
(DEGs)
high-GNGT1
group
participated
replication,
replication
preinitiation,
M
phase,
while
adhesion
molecules,
apoptosis,
natural
killer
cell-mediated
cytotoxicity
all
downregulated.
Messenger
RNA
protein
levels
correspondingly
regulated
human
Scgb1a1-Cre;
LSL-GNGT1
mouse
model
(GNGT1fl/+
mice).
tumor
proliferation
via
enhancement
stemness
interaction
driver
genes.
Elevated
promoted
epithelial-mesenchymal
transformation,
remodeled
microenvironment,
led
metastasis,
ultimately
worsening
survival-related
Language: Английский
Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma
Yizhe Zhang,
No information about this author
Yunshu Ma,
No information about this author
Ensi Ma
No information about this author
et al.
Cancer Drug Resistance,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 26, 2025
Hepatocellular
carcinoma
(HCC)
remains
a
serious
threat
to
global
health,
with
rising
incidence
and
mortality
rates.
Therapeutic
options
for
advanced
HCC
are
quite
limited,
the
overall
prognosis
poor.
Recent
advancements
in
immunotherapy,
particularly
immune-checkpoint
blockade
(ICB)
targeting
anti-PD1/PD-L1
anti-CTLA4,
have
facilitated
paradigm
shift
cancer
treatment,
demonstrating
substantial
survival
benefits
across
various
types,
including
HCC.
However,
only
subset
of
patients
exhibit
favorable
response
ICB
therapy,
its
efficacy
is
often
hindered
by
development
resistance.
There
many
studies
explore
underlying
mechanisms
response.
In
this
review,
we
compiled
latest
progression
immunotherapies
systematically
summarized
sophisticated
which
components
tumor
microenvironment
(TME)
regulate
resistance
therapy.
Additionally,
also
outlined
some
scientific
rationale
strategies
boost
antitumor
immunity
enhance
These
insights
may
serve
as
roadmap
future
research
help
improve
outcomes
patients.
Language: Английский
A Reliable Prognostic Model for Hepatocellular Carcinoma Using Neutrophil extracellular traps and immune Related Genes
Dahua Yuan,
No information about this author
Feng Zhang,
No information about this author
Pengfei Lv
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 6, 2025
Abstract
Background
Neutrophil
extracellular
traps
(NETs)
and
immunity
play
critical
roles
in
liver
hepatocellular
carcinoma
(LIHC)
progression,
but
their
mechanisms
remain
unclear.
This
study
explored
the
potential
of
NETs-related
genes
(NETs-RGs)
immune-related
(IRGs)
as
prognostic
markers
for
LIHC.
Methods
LIHC
transcriptome
data
IRGs
were
obtained
from
public
databases,
NETs-RGs
derived
prior
research.
Differentially
expressed
(DEGs)
intersecting
with
key
module
identified,
followed
by
Cox
regression
analysis
machine
learning
to
determine
genes.
A
risk
prediction
model
nomogram
constructed
validated.
Enrichment
analysis,
immune
infiltration,
drug
sensitivity
studies
conducted
explore
underlying
mechanisms.
Reverse
transcription
quantitative
PCR
(RT-qPCR)
was
used
validate
findings.
Results
Five
genes—
HMOX1,
MMP9,
TNFRSF4,
MMP12,
FLT3—were
identified.
demonstrated
strong
predictive
ability.
Gene
set
enrichment
revealed
pathways
related
retinol
metabolism
cytochrome
P450
different
groups.
Immune
infiltration
showed
regulatory
T
cells
positively
correlated
MDSCs,
which
directly
associated
five
Drug
identified
74
drugs
differential
between
groups;
axitinib
lower
high-risk
patients,
while
ABT-888
higher
sensitivity.
RT-qPCR
confirmed
reduced
HMOX1
FLT3
expression
tissues,
MMP9
TNFRSF4
upregulated.
Conclusion
developed
a
robust
prognosis,
offering
valuable
insights
clinical
management
personalized
treatment
strategies.
Language: Английский
Immune Checkpoint Inhibitors and Immunosuppressive Tumor Microenvironment: Current Challenges and Strategies to Overcome Resistance
G. Gill,
No information about this author
Simmi Kharb,
No information about this author
Gitanjali Goyal
No information about this author
et al.
Immunopharmacology and Immunotoxicology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 45
Published: May 16, 2025
Immune
checkpoint
inhibitors
(ICIs)
are
shown
to
improve
cancer
treatment
effectiveness
by
boosting
the
immune
system
of
patient.
Nevertheless,
unique
and
highly
suppressive
TME
poses
a
significant
challenge,
causing
heterogeneity
response
or
resistance
in
considerable
number
patients.
This
review
focuses
on
evasive
attributes
TME.
evasion
mechanism
include
immunosuppressive
cells,
cytokine
chemokine
signaling,
metabolic
alterations
overexpression
molecules
such
as
PD-1,
CTLA-4,
LAG-3,
TIM-3,
TIGIT,
BTLA
their
interactions
within
In
addition,
this
overcoming
targeting
normalizing
tumor
blood
vessels,
blocking
two
three
checkpoints
simultaneously,
combining
vaccines,
oncolytic
viruses
with
ICIs
other
therapies.
also
necessity
finding
predictive
markers
for
stratification
patients
check
treatment.
It
remains
be
made
certain
new
research
intelligent
innovations
how
these
discoveries
its
interplay
facilitate
ICI
change
face
Language: Английский
Neutrophil extracellular traps in rheumatoid arthritis: Activating fibroblast-like synoviocytes via ATP citrate lyase
Jun Li,
No information about this author
Xiaomin Wang,
No information about this author
Min Tan
No information about this author
et al.
International Immunopharmacology,
Journal Year:
2024,
Volume and Issue:
143, P. 113518 - 113518
Published: Nov. 12, 2024
Language: Английский
Global research trends and focus on the link between neutrophil extracellular traps and tumor: a bibliometric and visualization analysis from 2006 to 2024
Chaoyue Xiao,
No information about this author
Xiang Feng,
No information about this author
Zengyi Zhao
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 24, 2024
Background
Neutrophil
extracellular
traps
(NETs)
have
long
been
consistently
considered
an
innate
immune
defense
against
foreign
pathogens,
but
this
oversimplified
view
has
decelerated
the
progression
of
perceiving
NET
biology
in
chronic
diseases.
It
is
now
increasingly
accepted
that
NETs
are
not
exclusive
to
anti-infection
responses,
also
central
players
with
a
double-edged
sword
role
cancer
progression.
gradually
emerged
as
tumor
diagnostic,
predictive,
and
prognostic
biomarkers,
strenuous
endeavors
devoted
tapping
their
potential
new
therapeutic
targets.
Correspondingly,
boom
studies
on
tumors
recent
years
achieved
series
scientific
outputs,
which
opens
up
perspective
for
sophisticated
landscapes
microenvironment.
However,
there
still
much
room
translate
NET-targeted
immunotherapies
into
clinical
practice.
Therefore,
it
necessary
explore
knowledge
structure
latent
hotspots
links
between
using
bibliometric
analysis.
Methods
publications
from
2006
2024
were
extracted
Web
Science
Core
Collection.
Bibliometric
analysis
visualization
conducted
Microsoft
Excel,
VOSviewer,
CiteSpace,
R-bibliometrix.
Results
The
included
1,339
authored
by
7,747
scholars
affiliated
1,926
institutions
across
70
countries/regions
relevant
articles
published
538
journals.
Despite
China’s
maximum
number
publications,
United
States
continued
dominate
field
global
cooperation
center
overwhelming
citation
counts.
Frontiers
Immunology
most
whereas
Blood
was
cited
journal.
Wagner,
Denisa
D.
Kaplan,
Mariana
J.
concurrently
both
top
10
prolific
authors
author
lists.
Tumor
microenvironment
immunotherapy
will
likely
be
focus
future
research.
Conclusions
A
comprehensive
first
map
current
landscape
link
hope
providing
guidance
fresh
perspectives
further
research
field.
promising
antitumor
targets,
perhaps
eventual
destination
realm
Language: Английский
The Ketogenic Diet Modulates Tumor-Associated Neutrophil Polarization via the AMOT-YAP/TAZ Axis to Inhibit Colorectal Cancer Progression
Xiuwei Mi,
No information about this author
Yudong Duan,
No information about this author
Jiying Sun
No information about this author
et al.
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
210, P. 107494 - 107494
Published: Nov. 5, 2024
Despite
significant
advances
in
the
diagnosis
and
treatment
of
colorectal
cancer
(CRC),
prognosis
for
late-stage
patients
remains
poor,
highlighting
urgent
need
new
preventive
therapeutic
strategies.
Recent
studies
have
focused
on
ketogenic
diet
(KD)
its
metabolite,
β-hydroxybutyrate
(BHB),
their
tumor-suppressive
effects
modulation
inflammatory
responses.
Using
azoxymethane
(AOM)
/
dextran
sulfate
sodium
(DSS)-induced
mouse
CRC
model,
we
found
that
BHB
inhibit
pro-tumor
N2-type
tumor-associated
neutrophils
(TANs)
while
promoting
polarization
TANs
towards
anti-tumor
N1
type.
This
shift
affects
tumor
growth
metastasis.
The
underlying
mechanism
involves
acting
intracellular
receptor
histone
deacetylases
3
(HDAC3),
which
modulates
activation
AMOT-YAP/TAZ
axis,
leading
to
inhibition
pro-carcinogenic
factor
transcription
release.
Moreover,
clinical
cohort
data
corroborate
these
findings,
showing
with
elevated
levels
significantly
lower
rates
lymph
node
involvement,
is
associated
a
higher
infiltration
ratio
anti-carcinogenic
N1-type
microenvironment
(TME).
These
results
suggest
could
serve
as
prognostic
biomarker
CRC.
In
conclusion,
our
findings
indicate
derived
from
KD
regulates
via
HDAC3-AMOT-YAP/TAZ
effectively
inhibiting
insights
establish
novel
theoretical
basis
employing
developing
adjuvant
immunotherapy
strategy
based
neutrophils.
Language: Английский